The Meningococcal Vaccines Market to grow on an altruistic note (~ US$ 6.5 Billion) between 2029
The Meningococcal Vaccines Market Share is all set to witness a CAGR of 10% and reach ~ US$ 6.5 Billion between 2029. The present-day scenario is such that mobile technology has elevated patient care and empowered clinicians. The scenario is expected to continue even going forward. Tech-savvy patients have emerged and transformed the healthcare vertical digitally. The meningococcal vaccine market has expanded to a significant extent over the past few years in correspondence to the parent market. Constant research and development in meningococcal vaccines for various meningococcal disease preventive applications, coupled with the sanctions of subsidy & support of government organizations for immunization program are among the significant factors that are anticipated to drive the growth of the meningococcal vaccine market during the forecast period. Expansion of the age group indication related to new sero-groups is boosting the potential population pool, thus boo...